SRIVASTAVA SURESH C has a total of 17 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are ALCHEMIA PTY LTD, Shanghai ziyuan pharmaceutical co ltd and RISEN SUZHOU PHARMA TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Surface technology and coating | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Srivastava Suresh C | 17 |
#2 | Srivastava Naveen P | 5 |
#3 | Szymanski Jr Stanley J | 4 |
#4 | Srivastav Sant K | 3 |
#5 | Pandey Divya | 2 |
#6 | Yasko Amy | 2 |
#7 | Adzic Radoslav | 2 |
#8 | Gonzales Gilbert R | 2 |
#9 | Meinken George E | 2 |
#10 | Srivastay Sant K | 1 |
Publication | Filing date | Title |
---|---|---|
US2014039178A1 | Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides | |
US2014039175A1 | Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides | |
US2011137010A1 | Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA | |
US2010137970A1 | Method of electroplating a conversion electron emitting source on implant | |
USH819H | Palladium-109 labeled anti-melanoma monoclonal antibodies |